dr. bardia on the results of the ascent trial in previously treated metastatic tnbc
Published 4 years ago • 132 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
3:31
the ascent of sacituzumab govitecan in metastatic tnbc | aditya bardia
-
0:57
dr. bardia on the role of the microenvironment in tnbc
-
1:15
dr. bardia on the need to develop additional therapies in metastatic tnbc
-
3:05
esmo 2020 highlights on sacituzumab govitecan in metastatic tnbc: the ascent study
-
7:14
ascent: sacituzumab govitecan vs treatment of physician’s choice in patients with previously tre...
-
28:25
metastatic triple-negative breast cancer ongoing trials
-
2:44
dr aditya bardia forecasts what’s to come for the ascent trial in triple-negative breast cancer
-
1:15
the value of early diagnosis in amyloidosis and the impact of a delayed diagnosis for patients
-
1:27
dr bardia on current approaches to her2 breast cancer management
-
2:03
dr. bardia discusses recent advancements in the field of breast cancer
-
2:23
dr aditya bardia discusses the advantages of sacituzumab govitecan for triple-negative breast cancer
-
2:40
dr. bardia on sacituzumab govitecan in triple-negative breast cancer
-
3:10
ascent trial: sacituzumab govitecan for tnbc
-
1:47
dr. bardia on sacituzumab govitecan in tnbc
-
1:18
dr. bardia on potential concerns with biosimilars in breast cancer
-
4:25
ascent: sacituzumab govitecan shows promise in mtnbc patients
-
1:50
dr. domchek on results of the mediola trial in brca-mutated metastatic breast cancer
-
2:21
ascent: a randomized phase iii study of sacituzumab govitecan vs treatment of physician’s choice
-
5:24
biomarker data point to wide use of sacituzumab govitecan in advanced tnbc | sara hurvitz